Axsome Therapeutics (AXSM) will host its Frontiers in Brain Health R&D Day in New York City to review its industry-leading CNS pipeline. The Frontiers in Brain Health R&D Day will feature presentations from the following six leading expert clinicians and key opinion leaders, who will discuss the psychiatric and neurological conditions targeted by the company’s pipeline, and present clinical data from the pipeline programs.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXSM:
- Aptiv, IIPR, Huntington, PNC, Axsome Trending by Analysts
- Axsome Therapeutics assumed with an Overweight at Morgan Stanley
- Positive Outlook for Axsome Therapeutics Driven by Regulatory Progress and Commercial Success
- Axsome Therapeutics participates in Alzheimer’s, Brain Health Awareness Month
- Optimistic Buy Rating for Axsome Therapeutics Amid Promising Developments and Strategic Initiatives